Table of Contents Author Guidelines Submit a Manuscript
International Journal of Biomedical Imaging
Volume 2011, Article ID 953806, 12 pages
http://dx.doi.org/10.1155/2011/953806
Research Article

Feasibility of Imaging Myelin Lesions in Multiple Sclerosis

General Electric Global Research Center, 1 Research Circle, Niskayuna, NY 12309, USA

Received 13 January 2011; Revised 18 March 2011; Accepted 14 April 2011

Academic Editor: Kjell Erlandsson

Copyright © 2011 Maria I. Zavodszky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Charcot, Lectures on Diseases of the Nervous System, The New Sydenham Society, 1877.
  2. C. M. Poser, D. W. Paty, L. Scheinberg et al., “New diagnostic criteria for multiple sclerosis: guidelines for research protocols,” Annals of Neurology, vol. 13, no. 3, pp. 227–231, 1983. View at Google Scholar
  3. R. Lazzarini, Myelin Biology and Disorders, Elsevier Academic Press, Amsterdam, The Netherlands, 2004.
  4. J. M. Boggs, “Myelin basic protein: a multifunctional protein,” Cellular and Molecular Life Sciences, vol. 63, no. 17, pp. 1945–1961, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Nolte, The Human Brain: An Introduction to Its Functional Anatomy, Mosby, 2004.
  6. L. Wang, H. M. Lai, A. J. Thompson, and D. H. Miller, “Survey of the distribution of lesion size in multiple sclerosis: implication for the measurement of total lesion load,” Journal of Neurology Neurosurgery and Psychiatry, vol. 63, no. 4, pp. 452–455, 1997. View at Google Scholar · View at Scopus
  7. S. Kirk, J. A. Frank, and S. Karlik, “Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?” Journal of the Neurological Sciences, vol. 217, no. 2, pp. 125–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. G. J. Siegel, R. W. Albers, S. T. Brady, and D. L. Price, Basic Neurochemistry, Elsevier, Amsterdam, The Netherlands, 2006.
  9. R. Zivadinov and J. L. Cox, “Neuroimaging in multiple sclerosis,” International Review of Neurobiology, vol. 79, pp. 449–474, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Filippi, F. Barkhof, S. Bressi, T. A. Yousry, and D. H. Miller, “Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis,” Multiple Sclerosis Journal, vol. 3, no. 4, pp. 226–230, 1997. View at Google Scholar
  11. M. Filippi, P. Rossi, A. Campi, B. Colombo, C. Pereira, and G. Comi, “Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability,” American Journal of Neuroradiology, vol. 18, no. 8, pp. 1549–1556, 1997. View at Google Scholar · View at Scopus
  12. M. Filippi, T. Yousry, M. A. Rocca, G. Fesl, R. Voltz, and G. Comi, “Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis,” Acta Neurologica Scandinavica, vol. 95, no. 6, pp. 331–334, 1997. View at Google Scholar · View at Scopus
  13. E. Waubant, “Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis,” Disease Markers, vol. 22, no. 4, pp. 235–244, 2006. View at Google Scholar · View at Scopus
  14. D. Soon, D. R. Altmann, K. T. Fernando et al., “A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis,” Journal of Neurology, vol. 254, no. 3, pp. 306–314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G. J. Lycklama À Nijeholt, M. A. van Walderveen, J. A. Castelijns et al., “Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms,” Brain, vol. 121, part 4, pp. 687–697, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Stankoff, Y. Wang, M. Bottlaender et al., “Imaging of CNS myelin by positron-emission tomography,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9304–9309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Wu, J. Wei, D. Tian, Y. Feng, R. H. Miller, and Y. Wang, “Molecular probes for imaging myelinated white matter in CNS,” Journal of Medicinal Chemistry, vol. 51, no. 21, pp. 6682–6688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. The BioDMET Web Site, http://pdsl.research.ge.com/BioDMET.
  19. N. Parrott, N. Paquereau, P. Coassolo, and T. Lave, “An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery,” Journal of Pharmaceutical Sciences, vol. 94, no. 10, pp. 2327–2343, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Laule, I. M. Vavasour, G. R. Moore et al., “Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study,” Journal of Neurology, vol. 251, no. 3, pp. 284–293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. S. van der Knaap, “Myelin and white matter,” in Magnetic Resonance of Myelination and Myelin Disorders, M. S. van der Knaap and J. Valk, Eds., Springer, Berlin, Germany, 2005. View at Google Scholar
  22. I. M. Vavasour, C. Laule, D. K. Li et al., “Longitudinal changes in myelin water fraction in two MS patients with active disease,” Journal of the Neurological Sciences, vol. 276, no. 1, pp. 49–53, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Trotter, C. L. Wegescheide, and W. F. Garvey, “Regional studies of myelin proteins in human brain and spinal cord,” Neurochemical Research, vol. 9, no. 1, pp. 133–146, 1984. View at Google Scholar · View at Scopus
  24. J. L. Trotter, C. L. Wegescheide, W. F. Garvey, and W. W. Tourtellotte, “Studies of myelin proteins in multiple sclerosis brain tissue,” Neurochemical Research, vol. 9, no. 1, pp. 147–152, 1984. View at Google Scholar · View at Scopus
  25. J. Kamholz, F. de Ferra, C. Puckett, and R. Lazzarini, “Identification of three forms of human myelin basic protein by cDNA cloning,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 13, pp. 4962–4966, 1986. View at Google Scholar · View at Scopus
  26. I. G. Zubal, C. R. Harrell, E. O. Smith, Z. Rattner, G. Gindi, and P. B. Hoffer, “Computerized three-dimensional segmented human anatomy,” Medical Physics, vol. 21, no. 2, pp. 299–302, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Rorden and M. Brett, “Stereotaxic display of brain lesions,” Behavioural Neurology, vol. 12, no. 4, pp. 191–200, 2000. View at Google Scholar · View at Scopus
  28. Y. Shao, R. M. Manjeshwar, F. P. Jansen, and P. N. Kumar, “PSM: a PET system model capable of generating images with clinically relevant count density,” in Proceedings of the EEE Nuclear Science Symposium and Medical Imaging Conference, Portland, Ore, USA, October 2003.
  29. V. Bettinardi, M. Danna, A. Savi et al., “Performance evaluation of the new whole-body PET/CT scanner: discovery ST,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 6, pp. 867–881, 2004. View at Google Scholar · View at Scopus
  30. W. R. Hendee and E. R. Ritenour, Medical Imaging Physics, John Wiley & Sons, 2002.